well
establish
effici
immun
system
declin
increas
age
immunosenesc
caus
increas
suscept
infecti
diseas
infect
fact
third
lead
caus
mortal
peopl
age
albright
albright
even
case
mortal
issu
reduc
morbid
infect
older
peopl
urgent
need
order
improv
health
older
gener
clearli
appar
chapter
book
mani
compon
immun
system
chang
age
crucial
maintain
effect
immun
system
chapter
address
current
knowledg
agerel
chang
humor
immun
system
contribut
immun
frailti
older
person
primari
b
cell
respons
antibodi
recogn
pathogen
although
necessarili
high
affin
rapidli
produc
may
includ
socal
polyspecif
antibodi
abil
bind
multipl
antigen
meffr
wardemann
mouquet
et
al
scheid
et
al
first
antibodi
igm
class
crucial
opson
pathogen
induc
phagocytosi
activ
complement
cascad
antibodi
function
rapid
primari
respons
shown
play
vital
role
protect
extracellular
bacteri
pathogen
brown
et
al
tindependentrespons
gener
particularli
import
protect
bacteri
pathogen
extern
antigen
pathogen
nonprotein
natur
antibodi
afford
protect
viral
infect
neutral
viru
particl
bind
block
key
molecul
involv
cellular
infect
similarli
also
neutral
toxin
later
tdepend
affin
matur
b
cell
immun
respons
slower
result
gener
highli
specif
antibodi
often
differ
class
elderli
suscept
infect
wide
varieti
pathogen
involv
b
cell
antibodi
normal
cours
immun
respons
tabl
lung
common
mucos
surfac
gastrointestin
genitourinari
tract
particularli
vulner
infect
virtu
exposur
environ
illustr
tabl
pulmonari
infect
common
older
peopl
elderli
usual
first
affect
annual
epidem
respiratori
infect
frequent
suffer
worst
clinic
mortal
figur
attribut
influenza
pneumonia
confus
fact
influenza
often
follow
secondari
infect
notabl
streptococcu
pneumonia
brinkhof
et
al
van
der
sluij
et
al
seki
et
al
resolut
first
infect
leav
person
suscept
secondari
bacteri
infect
may
particular
concern
older
peopl
dunnwalt
ademokun
ademokun
et
al
report
pneumonia
influenza
death
respiratori
syncyti
viru
rsv
associ
death
occur
age
year
thompson
et
al
matia
et
al
oldest
old
year
increas
chanc
mortal
influenza
influenzaassoci
pneumonia
compar
age
year
thompson
et
al
prospect
studi
follow
healthi
elderli
show
approxim
twice
mani
peopl
rsv
infect
influenza
infect
period
year
patient
contract
either
influenza
rsv
falsey
et
al
predict
probabl
older
patient
communityacquir
pneumonia
cap
enter
hospit
within
day
contract
cap
millett
et
al
also
increas
incid
pneumococc
septicemia
old
peopl
associ
pneumonia
infect
mcintosh
et
al
weilolivi
et
al
known
specif
antibodi
gener
tdepend
b
cell
respons
crucial
protect
influenza
ineffect
influenzaspecif
antibodi
assess
hemagglutin
inhibit
hi
test
associ
lower
protect
diseas
goodev
et
al
said
agerel
decreas
influenza
protect
sole
account
reduc
cell
help
avail
diminish
elderli
cell
repertoir
howev
take
account
fact
cell
may
reli
fulli
function
b
cell
activ
rivera
et
al
crawford
et
al
area
humor
immun
b
cell
even
less
reliant
cell
help
pneumonia
bacteri
infect
caus
number
differ
organ
eg
streptococcu
pneumonia
staphylococcu
aureu
streptococcu
pyogen
although
pneumonia
major
caus
alonsodevelasco
et
al
birch
gowardman
hageman
et
al
immun
pneumonia
particularli
reliant
healthi
b
cell
popul
sinc
antigen
portion
pneumonia
capsular
polysaccharid
tindepend
type
ii
tiii
antigen
unlik
tdepend
b
cell
respons
matur
b
cell
antibodi
reli
cell
help
therefor
failur
respond
could
attribut
failur
cell
respons
independ
direct
cell
help
therefor
failur
protect
pneumonia
like
failur
ascrib
deficit
b
cell
children
reduc
pneumococc
respons
explain
lack
margin
zone
b
cell
spleen
main
tiii
respond
b
cell
thought
resid
howev
older
peopl
appear
fulli
function
splenic
margin
zone
banerje
et
al
b
cell
thought
recircul
equival
splenic
margin
zone
provid
protect
pneumonia
kruetzmann
et
al
show
agerel
chang
see
may
account
reduc
respons
tiii
antigen
remov
igm
human
serum
diminish
phagocytosi
pneumonia
vitro
assay
park
nahm
also
indic
igm
crucial
role
protect
pneumococc
diseas
complementari
discov
although
polysaccharidespecif
igg
equival
old
young
patient
vaccin
product
specif
igm
iga
antibodi
significantli
diminish
ademokun
et
al
although
pulmonari
infect
elderli
notabl
virtu
fact
caus
mortal
also
signific
increas
morbid
mortal
infect
bacteri
infectionsof
skin
urinari
tract
soft
tissu
gastrointestin
tract
increas
age
albright
albright
infect
organ
clostridium
difficil
candida
albican
seem
almost
exclus
older
age
group
fig
sepsi
particular
problem
older
peopl
sever
diseas
shown
correl
serum
level
igm
elderli
suzuki
et
al
vaccin
extrem
import
tool
prevent
death
infect
sinc
routin
administ
part
normal
healthcar
routin
main
sourc
data
immun
respons
man
consist
shown
effect
vaccin
sever
diminish
older
peopl
sinc
specif
antibodi
product
often
use
correl
protect
vaccin
studi
use
way
observ
humor
immun
respons
agerel
reduct
specif
antibodi
product
occur
respons
mani
vaccin
includ
hepat
b
fourati
et
al
pneumonia
simberkoff
et
al
koivula
et
al
et
al
rubin
janoff
tetanu
diphtheria
tickborn
enceph
hainz
et
al
weinberg
et
al
commonli
studi
vaccin
influenza
cellular
respons
ie
cell
releas
cytokin
macrophag
natur
killer
cell
decreas
age
igg
antibodi
titer
significantli
lower
goronzi
weyand
mcelhaney
et
al
vaccin
older
peopl
influenza
wide
accept
valid
health
strategi
reduc
diseas
incid
odelin
et
al
keitel
et
al
maciosek
et
al
diseas
mortal
may
affect
simonsen
et
al
rizzo
et
al
agreement
previou
studi
shown
older
peopl
fail
develop
protect
haemagglutinin
inhibit
hi
titer
follow
vaccin
ademokun
et
al
reber
et
al
recent
studi
investig
differ
vaccin
regim
effort
improv
protect
elderli
evid
boost
within
month
vaccin
improv
antibodi
respons
reduc
innat
respons
kannan
et
al
success
vaccin
improv
older
immun
respons
level
shown
younger
adult
et
al
case
influenza
respons
studi
recal
respons
may
complic
exist
slightli
crossreact
antibodi
form
previou
strain
influenza
studi
vaccin
respons
diseas
endem
countri
origin
circumv
travel
vaccin
hepat
also
show
reduc
specif
antibodi
respons
genton
et
al
other
yellow
fever
seem
show
undiminish
antibodi
respons
respons
take
longer
rouken
et
al
increas
risk
advers
event
older
peopl
monath
et
al
rouken
et
al
thoma
et
al
inflammatori
cytokin
secret
mani
differ
cell
worth
note
immun
cell
secret
inflammatori
cytokin
particularli
regard
agerel
chang
senescenceassoci
secretori
phenotyp
senesc
cell
must
also
consid
campisi
et
al
overal
environ
contribut
mani
cell
clear
whether
b
cell
make
signific
contribut
overal
inflammatori
milieu
although
evid
gradual
emerg
show
cytokin
profil
respons
chang
contribut
level
older
memori
b
cell
shown
secret
higher
level
turn
neg
correl
overal
immun
respons
particular
lower
level
activ
enzym
aid
b
cell
critic
affin
matur
respons
frasca
blomberg
increas
product
also
shown
older
b
cell
banco
phipp
reduct
b
cell
clinic
shown
amelior
autoimmun
diseas
barr
et
al
product
inflammatori
cytokin
older
b
cell
warrant
studi
welldocu
shift
toward
selfreact
antibodi
product
age
although
gener
associ
autoimmun
diseas
per
se
rheumatoid
arthriti
ra
agerel
inflammatori
autoimmun
disord
increas
rheumatoid
factor
rf
age
tempt
one
assum
causal
link
howev
increas
rf
occur
regardless
whether
subject
ra
andersenranberg
et
al
presenc
anoth
autoantibodi
anticycl
citrullin
peptid
associ
higher
risk
ra
antibodi
like
result
environment
factor
specif
smoke
michou
et
al
success
use
therapi
rituximab
util
monoclon
antibodi
ablat
peripher
b
cell
ampl
evid
b
cell
play
import
part
diseas
process
ra
role
antigenpres
cell
activ
cell
produc
cytokin
may
promin
autoantibodi
produc
bugatti
et
al
complic
understand
role
b
cell
ra
role
regul
outlin
anoth
agerel
autoimmun
diseas
ancaassoci
vascul
peak
incid
age
uk
watt
et
al
diseas
character
antineutrophil
cytoplasm
antibodi
anca
two
common
target
myeloperoxidas
mpoanca
proteinas
instanc
role
autoantibodi
seem
clear
inappropri
activ
neutrophil
lead
system
inflamm
affect
joint
lung
kidney
tissu
associ
older
age
impli
b
cell
toler
mechan
respect
anca
like
fail
elderli
howev
mention
mani
autoreact
antibodi
increas
age
pathogen
antinuclear
antibodi
ana
haveconsist
found
increas
old
absenc
diseas
swedish
longitudin
nona
immun
studi
nilsson
et
al
show
significantli
higher
ana
level
oldest
old
year
found
associ
correl
immun
risk
factor
eg
cell
ratio
cmv
seroposit
find
echo
finnish
studi
ana
posit
age
show
correl
surviv
level
serum
marker
inflamm
hurm
et
al
saw
signific
increas
igg
ana
autoantibodi
age
unaffect
vaccin
unlik
caus
bystand
activ
polyspecif
antibodi
respons
ademokun
et
al
agerel
increas
occur
antissdna
antibodi
manoussaki
et
al
xavier
et
al
ioannidi
et
al
cardiolipin
dsdna
understand
increas
autoantibodi
without
autoimmun
diseas
becom
easier
stop
think
antibodi
exclus
specif
one
antigen
lock
key
hypothesi
rather
believ
antibodi
certain
amount
polyreact
perhap
particularli
case
b
cell
tindepend
respond
b
cell
igm
memori
cell
rel
abil
bind
selfantigen
versu
non
selfantigen
determin
whether
antibodi
surviv
toler
mechan
highli
specif
antibodi
gener
later
respons
affin
matur
germin
center
tdepend
process
view
mind
increas
nonpathogen
autoantibodi
age
could
explain
relax
toler
mechan
caus
autoimmun
diseas
perhap
contributori
factor
toward
increas
incid
diseas
ra
vascul
data
lab
show
immunoglobulin
sequenc
characterist
remov
repertoir
central
toler
extent
remov
decreas
age
martin
et
al
popul
b
cell
lost
igd
mutat
ig
gene
includ
classswitch
antibodi
well
small
popul
igmonli
antibodi
hallmark
sign
memori
b
cell
activ
marker
present
surfac
wu
et
al
cell
increas
age
bulati
et
al
well
autoimmun
diseas
chronic
viral
infect
hiv
wei
et
al
moir
et
al
associ
frailti
lu
et
al
suggest
exhaust
b
cell
long
time
activ
longer
continu
respons
howev
level
mutat
ig
gene
cell
gener
lower
cell
wu
et
al
difficult
argu
activ
longer
time
also
suggest
popul
cell
contain
tissuelik
memori
b
cell
activ
tindepend
mechan
present
individu
therefor
receiv
cell
help
matur
zelm
et
al
see
evid
relat
clone
popul
lineag
analysi
show
one
consist
deriv
wu
et
al
coupl
data
show
charact
differ
popul
wu
et
al
inclin
think
popul
cell
contain
sin
bin
potenti
autoreact
b
cell
receiv
enough
accessori
cell
help
allow
continu
activ
matur
process
exclud
possibl
cellindepend
respond
potenti
type
cell
includ
case
increas
popul
age
impli
decreas
cell
help
allow
potenti
autoreact
antibodi
progress
andor
loss
earli
stage
toler
mechan
allow
autoreact
b
cell
peripher
milieu
broadli
gate
popul
cell
like
popul
heterogen
detail
individu
subset
type
may
lost
averag
process
popul
whole
measur
popul
cell
mice
identifi
agerel
b
cell
abc
accumul
age
specif
function
characterist
includ
predispos
toward
autoimmun
activ
naradikian
et
al
abc
antigen
present
high
level
mhc
ii
rubtsova
et
al
work
place
human
equival
cell
within
convent
human
phenotyp
subset
still
ongo
sinc
memori
subset
increas
age
contain
classswitch
cell
hypermut
gene
possibl
abc
fall
categori
particularli
associ
infect
autoimmun
made
abc
human
memori
cell
wei
et
al
moir
et
al
memori
cell
may
tissuerel
memori
popul
surfac
marker
indic
traffick
tissu
includ
mucosa
bulati
et
al
berkowska
et
al
relationship
abc
b
cell
identifi
leechang
et
al
increas
age
human
macaqu
mice
clear
also
increas
mhc
high
level
human
popul
appear
divid
two
group
respect
posit
leechang
et
al
detail
phenotyp
analysi
popul
need
reconcil
contradict
place
abc
context
function
popul
cell
thought
recircul
equival
splenic
margin
zone
b
cell
retain
igm
igd
also
mutat
ig
gene
express
surfac
dunnwalt
et
al
capolunghi
et
al
bagnara
et
al
import
tindepend
respons
antigen
pneumococc
polysaccharid
therefor
crucial
protect
bacteria
shi
et
al
popul
cell
decreas
age
martin
et
al
seriou
implic
antibacteri
immun
popul
extrem
heterogen
contain
possibl
tdepend
rel
switch
memori
cell
b
cell
equival
rothstein
quach
cell
respond
activ
neutrophil
puga
et
al
shown
cell
vari
rel
quantiti
igm
igd
surfac
within
popul
proport
differ
igmhiigdlo
versu
igmloigdhi
popul
chang
age
like
reflect
chang
proport
differ
function
subset
martin
et
al
b
reg
potent
suppressor
immun
respons
secret
contactdepend
mechan
yet
fulli
elucid
although
phenotyp
b
reg
yet
determin
alon
appear
identifi
seem
b
reg
mostli
found
transit
b
cell
popul
mauri
menon
popul
identifi
popul
cell
shown
decreas
age
duggal
et
al
van
der
geest
et
al
deleteri
consequ
control
inflammatori
respons
b
cell
subset
produc
suppress
cytokin
particular
igm
memori
popul
defin
rather
contactdepend
mechan
suppress
chang
age
duggal
et
al
capac
b
cell
produc
also
import
decreas
igm
memori
cell
age
mention
like
also
result
reduc
product
capac
inde
studi
van
der
geest
et
al
indic
product
b
cell
decreas
age
abil
produc
inflammatori
cytokin
unaffect
moreov
may
differenti
effect
differ
type
autoantibodi
sinc
ana
correl
product
abil
rf
van
der
geest
et
al
gener
increas
memori
cell
report
age
macallan
et
al
colonnaromano
et
al
memori
cell
often
describ
class
switch
distinct
igg
far
common
antibodi
circul
therefor
preval
literatur
howev
recent
year
evid
emerg
indic
differ
class
subclass
antibodi
critic
role
immun
respons
igaantibodi
thought
mucos
antibodi
huge
area
exposur
exogen
antigen
mucos
surfac
certainli
requir
special
effici
protect
physiolog
gut
undergo
signific
chang
age
much
work
requir
understand
complex
relationship
gut
physiolog
microbiota
mucos
immun
system
age
mabbott
et
al
charact
germin
center
peyer
patch
chang
age
indic
less
specif
antibodi
select
banerje
et
al
serum
iga
respons
pneumococc
vaccin
older
peopl
diminish
age
serum
igm
respons
ademokun
et
al
respons
form
small
part
overal
serum
immunoglobulin
respons
vaccin
thought
key
antipneumococc
function
serum
antibodi
park
nahm
furthermor
highthroughput
sequenc
studi
patient
exhibit
poor
resolut
immun
respons
vaccin
challeng
term
reduct
immunoglobulin
clonal
day
failur
ascrib
wu
et
al
vaccin
studi
compar
adult
age
age
consist
increas
level
rel
subclass
older
group
human
class
antibodi
produc
tindepend
antibodi
pneumococc
polysaccharid
limit
effector
abil
result
poor
affin
fcgamma
receptor
bruhn
et
al
younger
adult
show
signific
qualit
differ
use
ighv
famili
gene
repertoir
possibl
reflect
differ
activ
andor
toler
mechan
repertoir
select
contrast
repertoir
older
peopl
chang
resembl
seen
indic
possibl
chang
activationtoler
mechan
age
martin
et
al
textbook
view
antibodi
function
specif
affin
antigen
depend
fab
function
molecul
chang
class
switch
differ
fc
howev
shown
chang
class
antibodi
affect
fine
specif
class
switch
import
chang
effector
function
torr
et
al
togeth
result
suggest
futur
studi
humor
respons
includ
measur
class
antibodi
exclud
investig
potenti
signific
function
b
cell
gc
two
compart
establish
dark
zone
light
zone
follow
antigen
stimul
select
b
cell
migrat
converg
gc
fdc
make
contact
long
process
park
choi
differenti
centroblast
dark
zone
light
zone
lower
densiti
b
cell
park
choi
gatto
brink
bannard
et
al
fdc
stromal
cell
gc
play
key
role
regul
humor
immun
respons
tew
et
al
gatto
brink
unlik
antigenpres
cell
apc
fdc
present
intact
antigenantibodi
complex
cell
surfac
zhang
et
al
form
immun
complex
highli
immunogen
assist
gc
b
cell
prolifer
qin
et
al
li
et
al
bannard
et
al
centroblast
prolifer
dark
zone
gc
hypermut
immunoglobulin
ig
gene
encod
antibodi
occur
b
cell
move
light
zone
centrocyt
die
apoptosi
unless
receiv
rescu
signal
condit
effici
recognit
antigen
newli
form
b
cell
receptor
rescu
signal
provid
fdc
follicular
helper
tfh
cell
sage
sharp
sinc
fdc
cell
help
limit
competit
b
cell
therefor
select
b
cell
highest
affin
antigen
occur
result
b
cell
switch
class
antibodi
igm
iggigaig
also
requir
cell
help
b
cell
highaffin
antibodi
differenti
either
memori
b
cell
provid
effici
recal
respons
plasma
cell
secret
antibodi
address
possibl
agerel
chang
gc
reaction
three
main
area
prolifer
b
cell
hypermut
ig
gene
select
highaffin
antigenspecif
antibodi
defect
b
cell
prolifer
would
sever
consequ
gc
reaction
sinc
loss
cell
due
deleteri
mutat
acquir
hypermut
extrem
larg
pool
b
cell
requir
counter
therefor
also
larg
cell
type
prolifer
cell
reach
replic
senesc
telomer
end
chromosom
erod
divis
therefor
limit
amount
prolifer
one
cell
line
undergo
set
length
telomer
goronzi
weyand
shorter
telomer
lymphocyt
associ
higher
risk
develop
carcinoma
wu
et
al
higher
chanc
mortal
infecti
diseas
heart
diseas
peopl
year
old
cawthon
et
al
halaschekwien
et
al
shown
telomer
length
decreas
age
cell
lesser
extent
b
cell
son
et
al
marten
et
al
weng
howev
believ
prolif
capac
b
cell
gc
impair
way
result
old
age
telomeras
enzym
elong
telomer
upregul
gc
high
centroblast
higher
still
centrocyt
result
b
cell
leav
gc
peripheri
substanti
longer
telomer
first
enter
kb
longer
determin
southern
blot
norrback
et
al
memori
b
cell
telomer
averag
bp
longer
b
cell
marten
et
al
much
debat
whether
overal
size
number
gc
chang
age
rodent
model
shown
decreas
gc
size
number
gonzalezfernandez
et
al
aydar
et
al
kolar
et
al
immunohistochem
studi
measur
size
overal
number
b
cell
follicl
human
spleen
peyer
patch
banerje
et
al
lymph
node
lazuardi
et
al
shown
agerel
differ
howev
two
studi
human
tonsil
perform
flow
cytometri
rather
measur
individu
gc
size
report
decreas
gc
b
cell
age
kolar
et
al
mattila
tarkkanen
tissuespecif
differ
may
account
discrep
work
would
need
clarifi
issu
mutat
introduc
somat
hypermut
gener
point
mutat
though
insert
delet
may
occur
tend
area
contain
hotspot
motif
rogozin
kolchanov
spencer
et
al
rogozin
diaz
conflict
opinion
regard
whether
quantit
chang
hypermut
age
individu
report
indic
chang
decreas
increas
mutat
increas
age
fact
studi
agre
hardli
surpris
take
account
patient
health
histori
ie
prior
immun
respons
tissu
origin
sampl
also
make
signific
differ
number
mutat
observ
exampl
shown
consist
b
cell
mucos
origin
higher
level
mutat
say
spleen
blood
banerje
et
al
address
issu
assess
frequenc
shm
individu
b
cell
gc
expans
histolog
defin
area
gc
spleen
peyer
patch
follicl
young
old
human
isol
mutat
lineag
particular
gc
reaction
count
banerje
et
al
dunnwalt
et
al
differ
frequenc
mutat
occur
human
gc
reaction
spleen
peyer
patch
age
lineag
tree
construct
furnish
inform
affin
matur
dynam
measur
lineag
tree
shape
paramet
sinc
failur
adequ
select
could
result
product
popul
cell
low
affin
seen
elderli
investig
lineag
tree
gc
reaction
sampl
patient
differ
age
select
differ
found
signific
decreas
degre
select
pressur
act
gc
b
cell
peyer
patch
gut
spleen
banerje
et
al
dunnwalt
et
al
explan
appar
chang
select
still
elus
sever
factor
could
contribut
may
sole
failur
qualiti
b
cell
term
specif
signal
function
howev
sinc
fdc
cell
import
select
process
also
good
candid
investig
failur
select
pressur
welldocu
agerel
declin
thymu
size
reduc
cell
output
chang
cell
popul
dramat
face
chronic
viral
infect
cmv
wistubahamprecht
et
al
chang
cell
number
much
modest
result
ratio
good
marker
immun
senesc
littl
inform
whether
human
follicular
helper
cell
tfh
gc
chang
age
ligand
tfh
interact
express
b
cell
relationship
critic
celldepend
activ
b
cell
prolifer
memori
format
classswitch
recombin
gc
age
cell
mice
shown
reduc
express
eaton
et
al
higher
product
ifn
lefebvr
et
al
chang
correl
decreas
igg
level
reminisc
decreas
igg
product
respons
influenza
vaccin
human
suggest
function
fdc
declin
increas
age
aydar
et
al
shikh
et
al
defect
may
intrins
fdc
may
failur
fdcb
cell
interact
fdc
fc
receptor
complement
receptor
surfac
retain
antigen
immun
complex
yoshida
et
al
interact
crucial
signal
activ
antigenspecif
b
cell
older
fdc
fail
properli
support
gener
memori
b
cell
induc
reduc
number
germin
center
aydar
et
al
like
result
reduc
capac
hold
immun
complex
szakal
et
al
decreas
immun
complex
retent
present
b
cell
would
lead
lower
b
cell
activ
gc
although
clearli
role
accessori
cell
failur
agerel
chang
germin
center
respons
chang
intrins
b
cell
also
respons
key
enzym
affin
matur
b
cell
activationinduc
cytidin
deaminas
aid
directli
respons
hypermut
ig
gene
class
switch
aid
express
regul
transcript
factor
aid
express
reduc
old
b
cell
frasca
et
al
reduct
turn
due
action
tristetraprolin
control
rna
stabil
frasca
et
al
consequ
reduc
aid
function
given
import
affin
matur
would
predict
reduct
highaffin
antibodi
inde
polyclon
antibodi
respons
produc
respons
vaccin
lower
affin
level
aid
lower
level
aid
also
seen
decreas
age
khurana
et
al
intrins
b
cell
chang
occur
decis
whether
differenti
memori
cell
plasma
cell
pc
depend
regul
transcript
factor
klein
dallafavera
martin
calam
shown
significantli
reduc
ex
vivo
b
cell
older
peopl
frasca
et
al
older
peopl
less
plasma
cell
bone
marrow
pritz
et
al
prior
advent
highthroughput
sequenc
method
best
gener
assess
repertoir
divers
use
spectratyp
analysi
would
give
quantit
estim
repertoir
disrupt
base
diverg
away
gaussian
distribut
length
way
could
show
dysregul
repertoir
common
older
peopl
associ
frailti
gibson
et
al
spectratyp
also
indic
failur
resolut
immun
respons
might
occur
older
peopl
signific
chang
length
overal
ademokun
et
al
howev
although
spectratyp
rel
inexpens
way
investig
larg
cohort
individu
qualit
inform
repertoir
whole
even
highthroughput
repertoir
sequenc
limit
come
sampl
whole
repertoir
boyd
et
al
number
studi
confirm
presenc
agerel
chang
clonal
expans
wu
et
al
jiang
et
al
chang
charact
wu
et
al
wang
et
al
martin
et
al
chang
class
switch
subclass
distribut
rubelt
et
al
galson
et
al
martin
et
al
evid
human
mechan
creat
divers
antibodi
repertoir
chang
age
therefor
assum
chang
repertoir
occur
age
result
subsequ
environment
select
forc
posit
select
event
huge
differ
repertoir
antigenspecif
cell
expand
instanc
undergo
affin
matur
germin
center
outlin
event
affect
age
affect
memori
b
cell
repertoir
one
key
differ
repertoir
immun
respons
size
physicochem
charact
region
region
crucial
antigen
bind
wu
et
al
occur
regardless
activ
antigen
first
sight
might
seem
small
size
benefici
exogen
antigen
bind
howev
also
decreas
size
b
cell
matur
bone
marrow
like
explan
larger
size
deleteri
way
presum
autoreact
potenti
remov
repertoir
crucial
decreas
size
obviou
sampl
older
peopl
dunnwalt
indic
tolerogen
select
event
decreas
older
peopl
perhap
provid
explan
observ
increas
autoreact
antibodi
age
discuss
number
area
physiolog
system
interact
immun
system
sinc
age
whole
bodi
phenomenon
need
take
holist
view
mechan
immun
failur
crossdisciplinari
work
requir
rare
studi
indic
import
lesson
learn
provid
tantal
glimps
complex
interrelationship
metabol
process
import
cell
immun
cell
except
although
data
limit
transcript
analysi
shown
associ
memori
b
cell
gener
cholesterollipid
metabol
pathway
influenza
vaccin
haralambieva
et
al
similarli
mice
transcriptom
analysi
identifi
metabol
pathway
er
stress
respons
pathway
chang
age
valid
studi
show
defect
glucos
catabol
oxid
phosphoryl
increas
reactiv
oxygen
speci
b
cell
age
kannan
et
al
sinc
obes
metabol
syndrom
increas
age
bmi
studi
subject
may
confound
factor
agerel
b
cell
studi
obes
associ
attenu
influenza
vaccin
respons
decreas
percentag
switch
memori
transit
b
cell
increas
percentag
proinflammatori
lateexhaust
memori
b
cell
frasca
et
al
human
b
cell
identifi
viscer
adipos
tissu
may
well
protect
effect
harmon
et
al
howev
also
suggest
b
cell
activ
product
lipolysi
viscer
adipos
tissu
releas
proinflammatori
mediat
thu
contribut
local
system
inflamm
nikolajczyk
mtor
pathway
autophagi
unfold
protein
respons
process
associ
age
perl
taylor
zhang
et
al
also
shown
import
plasma
cell
function
tellier
et
al
arnold
et
al
sinc
plasma
cell
number
bone
marrow
older
peopl
report
decreas
age
pritz
et
al
may
common
cellular
chang
age
particularli
relev
humor
immun
respons
circadian
rhythm
effect
physiolog
known
chang
age
bank
et
al
chronic
blood
lymphocyt
composit
includ
b
cell
observ
younger
adult
decreas
age
mazzoccoli
et
al
chronic
therefor
like
import
determin
respons
challeng
inde
studi
older
adult
age
found
antibodi
respons
vaccin
influenza
greater
vaccin
administ
morn
afternoon
long
et
al
exact
mechan
chronic
affect
immun
system
known
mani
homeostat
physiolog
mediat
also
vari
time
one
possibl
effect
cortisol
report
stress
depress
efficaci
immun
system
old
age
duggal
et
al
fact
particularli
relev
health
wellb
older
peopl
often
subject
stress
ill
health
bereav
mani
differ
aspect
immun
affect
imbal
dheacortisol
includ
lower
antibodi
product
b
cell
buford
willoughbi
exercis
nutrit
habit
older
peopl
also
affect
movementrestrict
comorbid
issu
dentit
humor
immun
dramat
affect
lack
exercis
hoff
et
al
poor
nutrit
affect
larg
number
differ
immun
paramet
lesourd
nutrit
chang
affect
microbiota
experi
mice
clearli
show
chang
b
cell
develop
respons
chang
tryptophan
avail
microbi
divers
van
beek
et
al
clear
rel
simpl
chang
lifestyl
factor
substanti
effect
immun
function
expans
b
cellsplasma
cell
absenc
appar
exogen
challeng
could
due
number
factor
may
inde
true
decreas
b
cell
output
face
homeostat
mechan
keep
total
number
b
cell
result
repertoir
increasingli
made
antigenexperienc
expans
cell
may
actual
underli
infect
normal
febril
symptom
recogn
infect
show
due
effect
immun
senesc
failur
resolv
respons
prior
infect
time
manner
highthroughput
repertoir
studi
individu
known
seroposit
statu
chronic
viral
infect
cmv
ebv
shown
ebv
cmv
caus
increas
clonal
expans
repertoir
wang
et
al
altern
may
patholog
monoclon
expans
b
cell
seen
leukemia
lymphoma
usual
diagnos
condit
individu
sort
medic
histori
exclud
studi
b
cell
divers
howev
might
possibl
preclin
condit
exist
peopl
increas
monoclon
expans
b
cell
phenotyp
previous
report
older
peopl
ghia
et
al
monoclon
gammopathi
undetermin
signific
mgu
predomin
plasma
cell
disord
kyle
et
al
shown
increas
age
human
kyle
et
al
mous
radl
character
increas
presenc
serum
monoclon
ig
mgu
found
young
subject
preval
around
report
vari
elderli
kyle
et
al
associ
mgu
onset
multipl
myeloma
relat
malign
condit
averag
risk
assess
per
year
kyle
vincent
rajkumar
vaccin
studi
mgu
patient
show
poor
vaccin
respons
indic
recruit
b
cell
immun
respons
compromis
prior
exist
expand
clone
tete
et
al
henc
one
danger
mgu
potenti
transform
malign
later
life
anoth
key
risk
suscept
infect
one
might
assum
older
peopl
without
mgu
inappropri
expans
b
cell
mention
would
also
case
malign
b
cell
myeloma
ageassoci
prime
exampl
chronic
lymphocyt
leukemia
cll
thought
aris
premalign
monoclon
b
cell
lymphocytosi
mbl
also
carri
risk
suscept
infect
whitak
et
al
ghia
b
cell
receptor
encod
cll
autoreact
herv
et
al
henc
think
expans
potenti
autoreact
b
cell
older
age
like
contributor
malign
transform
event
presenc
b
cell
sever
tumor
type
colorect
breast
lung
gastric
cancer
strongli
associ
improv
prognosi
number
studi
nelson
hennequin
et
al
may
result
role
antigenpres
cell
thu
aid
tumorinfiltr
cell
may
function
depend
antibodi
nelson
leechang
et
al
interest
note
ageassoci
b
cell
make
excel
antigenpres
cell
activ
cell
therefor
stimul
antitumor
activ
leechang
et
al
b
cell
infiltr
may
diffus
aggreg
tertiari
lymphoid
structur
case
recapitul
germin
center
morpholog
clonal
expans
switch
b
cell
shown
melanoma
presenc
b
cell
also
thought
benefici
saul
et
al
howev
experi
mice
indic
tumorinfiltr
b
cell
regulatori
caus
downregul
antitumor
respons
presenc
b
reg
number
solid
tumor
eg
pancreat
ovarian
esophag
hepatocellular
carcinoma
predict
aid
tumor
growth
inhibit
cell
activ
promot
inflammatori
growth
effect
schwartz
et
al
b
reg
human
pbmc
igm
class
perhap
distinguish
tumor
b
cell
class
antibodi
might
aid
discrimin
differ
function
effect
suggest
age
human
monocyt
convert
b
cell
regulatori
capac
antitumor
b
cell
leechang
et
al
seem
much
work
need
elucid
exact
role
tumorinfiltr
b
cell
differ
type
tumor
recent
year
role
b
cell
immun
respons
recogn
much
simpli
factori
produc
antibodi
thu
field
b
cell
immunolog
excit
phase
mani
unansw
question
respect
immun
regul
tumor
immun
respons
topic
particular
import
older
peopl
addit
much
scope
investig
b
cell
respons
outsid
textbook
tdepend
antibodi
product
mani
key
agerel
chang
tindepend
respons
would
involv
igm
iga
particularli
mucos
surfac
mucos
surfac
often
first
encount
extern
pathogen
may
involv
educ
host
humor
immun
system
respect
distinguish
inappropri
activ
signal
overal
pictur
current
b
cell
immun
age
system
suffici
number
qualiti
start
develop
breakdown
select
control
balanc
appropri
versu
inappropri
activ
signal
